Royalty Pharma plc (RPRX)
RPRX price $62.85 +0.70 +1.12%
- Ticker
- RPRX
- Price
- $62.85
- Change
- +0.70 +1.12%
- Market cap
- $27.98B
- P/E
- 25.78
- Forward P/E
- 11.81
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Stocklytics score
- 52
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was…